跳至主要内容
临床试验/CTRI/2011/10/002097
CTRI/2011/10/002097招募中4 期

Randomized controlled trial of evaluation of safety, efficacy and pharmacoeconomics of sodium feredetate and ferrous fumarate in the iron deficiency anemia (IDA) in a tertiary care hospital in central India

none0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Children of either gender age group 9-12 years with mild, moderate IDA
  • 2. Adult age group >12-50 years with mild and moderate IDA
  • 3. Serum creatinine less than 1.5 mg/dl at screening
  • 4. Hb level <11.5 in children(5-11 yrs), <12 in children (12-14 yrs) & non-pregnant women, <13 in adult men
  • 5. Serum ferritin <15 µg/l
  • 6. Obtained written informed consent

排除标准

  • 1. Severe anaemia ( <8gm/dl).
  • 2. Pregnant females and Lactating mothers.
  • 3. Patients with bleeding piles, mennorrhagia, chronic diarrhea.
  • 4. Patient taking any interacting drug affecting iron absorption like antacids, ascorbic
  • acids, antibiotics (tetracycline, quinolones)
  • 5. S. Creatinine >1.5 mg/dl
  • 6. Known hypersensitivity to any components of sodium feredetate or ferrous fumarate
  • 7. Pregnant or sexually -active females who are of childbearing potential and who are
  • not willing to use an acceptable form of contraception
  • 8. Alcohol or any drug abuse within past six months
  • 9. Any other laboratory abnormality, medical condition or psychiatric disorders which
  • put the subjectâ??s disease management at risk or may result in the subject being
  • unable to comply with the study.

研究者

发起方
none

相似试验